This article was originally published in The Gray Sheet
Perkin-Elmer: PerSeptive Biosystems subsidiary plans to redeem all of its 8-1/4% convertible subordinated notes due 2001 on March 23. The redemption price will be paid in cash and equal $1,055.81 per $1,000 principal amount of the notes, "which represents the redemption premium and aggregate principal plus accrued and unpaid interest to the redemption date," the firm states. The notes, for which the aggregate outstanding principal amount is $27.2 mil., are joint obligations of Perkin-Elmer and PerSeptive Biosystems, which was acquired by Perkin-Elmer on Jan. 22 ("The Gray Sheet" Jan. 26, In Brief)...
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.